BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Knopp NeuroSciences 

100 Technology Drive
Suite 440
Pittsburgh  Pennsylvania  15219  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Biogen Idec, Inc. (Massachusetts) (BIIB) Asked in Suit to Return ALS Biosamples to Knopp NeuroSciences 3/11/2013 8:42:01 AM    More...
Knopp NeuroSciences Forms New Parent Company, Knopp Biosciences to Expand Operations and Mission 10/14/2010 7:33:53 AM    More...
Biogen, Inc. Buys License to Late-Stage Nerve Disease Pill From Knopp NeuroSciences for $345 Million 8/18/2010 7:13:46 AM    More...
Knopp NeuroSciences Presents Further Encouraging Trends in Its Phase 2 Study of KNS-760704 (Dexpramipexole) in ALS 4/16/2010 11:38:56 AM    More...
Knopp NeuroSciences Reports Presentation of Encouraging Clinical Trends in a Phase 2 Study of KNS-760704 in ALS 12/9/2009 9:41:20 AM    More...
Knopp NeuroSciences Receives FDA Fast Track Designation for KNS-760704 in ALS 9/2/2009 10:19:30 AM    More...
Knopp NeuroSciences to Present Phase 2 Results of KNS-760704 in ALS 8/11/2009 10:10:53 AM    More...
European Commission Awards Orphan Designation to Knopp NeuroSciences' KNS-760704 in ALS 3/10/2009 9:17:00 AM    More...
Knopp NeuroSciences Completes Series B2 Financing, Raising Total Capitalization to $27 Million 11/19/2008 6:20:40 AM    More...
Knopp NeuroSciences Initiates Phase 2 Study of KNS-760704 in Amyotrophic Lateral Sclerosis 4/7/2008 9:15:39 AM    More...
12

//-->